Pterostilbene

A short randomized trial reports lower blood pressure alongside increased LDL cholesterol. Both findings matter when interpreting the evidence.

A change in a laboratory marker, a test score and everyday function are different outcomes. A statistically detectable result does not by itself tell us whether someone would notice a worthwhile difference.

Check the measured endpoint, comparison and study population. The full profile preserves effect estimates and the source's clinical-significance assessment, including when that assessment is not supplied.

The claim to test: Lower blood pressure alone establishes a net healthy-aging benefit.

What the reviewed records say:

The gap: Long-term clinical outcomes and the broader literature review remain unresolved; detailed adverse-event review is pending.

Durability, effects in other populations and healthy-lifespan outcomes need their own evidence.

Independent replication, meaningful human outcomes, longer follow-up and better safety reporting would make these results easier to interpret.

Long-term clinical outcomes and the broader literature review remain unresolved; detailed adverse-event review is pending.